|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shaukat A, Mongin SJ, Geisser MS, Lederle
FA, Bond JH, Mandel JS and Church TR: Long-term mortality after
screening for colorectal cancer. N Engl J Med. 369:1106–1114. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Eichhorn JM, Alford SE, Sakurikar N and
Chambers TC: Molecular analysis of functional redundancy among
anti-apoptotic Bcl-2 proteins and its role in cancer cell survival.
Exp Cell Res. 322:415–424. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cast A, Valanejad L, Wright M, Nguyen P,
Gupta A, Zhu L, Shin S and Timchenko N: C/EBPα-dependent
pre-neoplastic tumor foci are the origin of hepatocellular
carcinoma and aggressive pediatric liver cancer. Hepatology.
67:1857–1871. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tan EH, Hooi SC, Laban M, Wong E, Ponniah
S, Wee A and Wang ND: CCAAT/enhancer binding protein alpha knock in
mice exhibit early liver glycogen storage and reduced
susceptibility to hepatocellular carcinoma. Cancer Res.
65:10330–10337. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen Y, Costa RM, Love NR, Soto X, Roth M,
Paredes R and Amaya E: C/EBPalpha initiates primitive myelopoiesis
in pluripotent embryonic cells. Blood. 114:40–48. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
McFie PJ, Wang GL, Timchenko NA, Wilson
HL, Hu X and Roesler WJ: Identification of a co-repressor that
inhibits the transcriptional and growth-arrest activities of
CCAAT/enhancer binding protein alpha. J Biol Chem. 281:18069–18080.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fukuchi Y, Shibata F, Ito M, Goto-Koshino
Y, Sotomaru Y, Ito M, Kitamura T and Nakajima H: Comprehensive
analysis of myeloid lineage conversion using mice expressing an
inducible form of C/EBP alpha. EMBO J. 25:3398–3410. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Reddy SD, Pakala SB, Ohshiro K, Rayala SK
and Kumar R: MicroRNA-661, a c/EBPα target, inhibits metastatic
tumor antigen 1 and regulates its functions. Cancer Res.
69:5639–5642. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Benson AB III, Venook AP, Cederquist L,
Chan E, Chen YJ, Cooper HS, Deming D, Engstrom PF, Enzinger PC,
Fichera A, et al: Colon Cancer, Version 1.2017, NCCN clinical
practice guidelines in oncology. J Natl Compr Canc Netw.
15:370–398. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mestdagh P, Feys T, Bernard N, Guenther S,
Chen C, Speleman F and Vandesompele J: High-throughput stem-loop
RT-qPCR miRNA expression profiling using minute amounts of input
RNA. Nucleic Acids Res. 36:e1432008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rask K, Thörn M, Pontén F, Kraaz W,
Sundfeldt K, Hedin L and Enerbäck S: Increased expression of the
transcription factors CCAAT-enhancer binding protein-beta
(C/EBBeta) and C/EBzeta (CHOP) correlate with invasiveness of human
colorectal cancer. Int J Cancer. 86:337–343. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yong KJ, Basseres DS, Welner RS, Zhang WC,
Yang H, Yan B, Alberich-Jorda M, Zhang J, de Figueiredo-Pontes LL,
Battelli C, et al: Targeted BMI1 inhibition impairs tumor growth in
lung adenocarcinomas with low CEBPα expression. Sci Transl Med.
8:350ra1042016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Basu N, Saha S, Khan I, Ramachandra SG and
Visweswariah SS: Intestinal cell proliferation and senescence are
regulated by receptor guanylyl cyclase C and p21. J Biol Chem.
289:581–593. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhen C, Chen L, Zhao Q, Liang B, Gu YX,
Bai ZF, Wang K, Xu X, Han QY, Fang DF, et al: Gankyin promote
breast cancer cell metastasis by regulating Racl activity.
Oncogene. 32:3452–3460. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Geng L, Sun B, Gao B, Wang Z, Quan C, Wei
F and Fang XD: MicroRNA-103 promotes colorectal cancer by targeting
tumor suppressor DICER and PTEN. Int J Mol Sci. 15:8458–8472. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen J, Zheng B, Wang C, Chen Y, Du C,
Zhao G, Zhou Y and Shi Y: Prognostic role of microRNA-100 in
various carcinomas: Evidence from six studies. Tumour Biol.
35:3067–3071. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu Y, Sheng J, Dai D, Liu T and Qi F:
Smad4 acts as tumor suppressor by antagonizing lmphangiogenesis in
colorectal cancer. Pathol Res Pract. 211:286–292. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zaragoza K, Bégay V, Schuetz A, Heinemann
U and Leutz A: Repression of transcriptional activity of C/EBPalpha
by E2F-dimerization partner complexes. Mol Cell Biol. 30:2293–2304.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang GL, Shi X, Salisbury E, Sun Y,
Albrecht JH, Smith RG and Timchenko NA: Cyclin D3 maintains
growth-inhibitory activity of C/EBPalpha by stabilizing
C/EBPalpha-cdk2 and C/EBPalpha-Brm complexes. Mol Cell Biol.
26:2570–2582. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang H, Iakova P, Wilde M, Welm A, Goode
T, Roesler WJ and Timchenko NA: C/EBPalpha arrests cell
proliferation through direct inhibition of Cdk2 and Cdk4. Mol Cell.
8:817–828. 2001. View Article : Google Scholar : PubMed/NCBI
|
